Name (Synonyms) | Correlation | |
---|---|---|
drug1534 | LEAF-4L6715 Wiki | 1.00 |
drug1535 | LEAF-4L7520 Wiki | 1.00 |
Name (Synonyms) | Correlation | |
---|---|---|
D013577 | Syndrome NIH | 0.10 |
D055371 | Acute Lung Injury NIH | 0.10 |
D012127 | Respiratory Distress Syndrome, Newborn NIH | 0.09 |
D012128 | Respiratory Distress Syndrome, Adult NIH | 0.08 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
A sequential combination of different antibodies test against SARS-CoV-2 is evaluated. The protocol included a rapid test and several ELISA tests within a defined cohort of healthcare workers.
Description: Rate of anti-SARS-CoV-2 Antibodies
Measure: Seroprevalence Time: through study completion, maximum of one yearDescription: Kappa statistics
Measure: Agreement of the test results and questionnaire Time: through study completion, maximum of one year